https://www.marketscreener.com/quote/stock/ATARA-BIOTHERAPEUTICS-INC-16917577/news/Atara-Biotherapeutics-Announces-Primary-Analysis-Data-from-Phase-2-EMBOLD-Clinical-Trial-of-ATA188-i-45278984/?utm_source=telegram&utm_medium=social&utm_campaign=share